कृपया अन्य खोज का प्रयास करें
Shanghai Bio-heart Biological Technology Co., Ltd. operates as an interventional cardiovascular device company in the People’s Republic of China. The company focuses on the provision of bioresorbable scaffolds (BRS) and renal denervation (RDN) therapies for the treatment of coronary artery diseases and uncontrolled and resistant hypertension. It is developing Bioheart, a BRS system used in percutaneous coronary intervention procedures for the treatment of coronary artery disease; Iberis 2nd, a multi-electrode RDN product candidate; and drug coated balloon, a sirolimus drug-eluting balloon catheter designed for instent restenosis. The company has collaboration agreements with Terumo (China) Investment Co., Ltd. to conduct clinical trials for Iberis 2nd. Shanghai Bio-heart Biological Technology Co., Ltd. was founded in 2014 and is headquartered in Shanghai, the People’s Republic of China.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Peili Wang | - | 2023 | Executive Director |
Peili Wang | 39 | 2014 | Financial Manager & Executive Director |
Sheung Wai Chan | 69 | 2020 | Independent Non-Executive Director |
Yunqing Wang | 38 | 2020 | CFO, Joint Company Secretary & Executive Director |
Li Wang | 55 | 2014 | Executive Chairman of the Board, CEO & GM |
Xubo Lu | 42 | 2020 | Independent Non-Executive Director |
Wing Yiu Djen | - | 2023 | Independent Non-Executive Director |
Junyi Wang | 34 | 2023 | Employee Representative Supervisor |
Tao Cai | 37 | 2020 | Chairperson of the Board of Supervisors & Head of Technology of BRS |
Lei Zhu | 38 | 2022 | Supervisor |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है